CLINICAL_TRIALS
withdrawal
· 2016-05-12
Clinical Trial Update: Ursodeoxycholic Acid And Cholestasis Of Pregnancy [Phase 3]
Summary
A Phase 3 trial evaluating ursodeoxycholic acid for intrahepatic cholestasis of pregnancy has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Bologna | Conditions: Intrahepatic Cholestasis of Pregnancy | Phase 3 | Status: WITHDRAWN